Freenome, Inc. (FRNM) Current Ratio
- Current ratio · latest quarter: Value 0.20×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 0.20× | Current assets / current liabilities. $742.15K ÷ $3.63M ≈ 0.20× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 742.15K USD | Assets, Current |
| Current obligations | 3.63M USD | Liabilities, Current |
| Cash and equivalents | (m) | |
| Short-term securities | (m) | |
| Customer receivables | (m) | |
| Inventory | (m) | |
| Payables | (m) | |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $742.15K | $3.63M | (m) | (m) | (m) | (m) | (m) | (m) | 0.20× |
| 2026-03-31 | $649.66K | $2.86M | (m) | (m) | (m) | (m) | (m) | (m) | 0.23× |
| 2025-12-31 | $907.57K | $2.25M | (m) | (m) | (m) | (m) | (m) | (m) | 0.40× |
| 2025-09-30 | $1.26M | $934.56K | (m) | (m) | (m) | (m) | (m) | (m) | 1.35× |
| 2025-06-30 | $1.47M | $281.15K | (m) | (m) | (m) | (m) | (m) | (m) | 5.21× |
| 2025-03-31 | $1.34M | $265.57K | (m) | (m) | (m) | (m) | (m) | (m) | 5.06× |
| 2024-12-31 | $1.24M | $210.81K | (m) | (m) | (m) | (m) | (m) | (m) | 5.90× |
| 2024-09-30 | $1.37M | $159.98K | (m) | (m) | (m) | (m) | (m) | (m) | 8.56× |
| 2024-06-30 | $1.43M | $28.36K | (m) | (m) | (m) | (m) | (m) | (m) | 50.57× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |